Psychoactive substances act (United Kingdom 2016)

The Psychoactive Substances Act 2016 (PSA) is a controversial law in the United Kingdom intended to restrict the production, sale and supply of psychoactive substances. The bill was passed given Royal Assent on 28 January 2016, and came into force on 26 May 2016 across the entire United Kingdom. Legal scholars and human rights activists have criticized the legal PSA on legal and moral grounds and researchers have argued that the classification specified in the PSA is not evidence based and therefore scientifically invalid.
ukpga_20160002_en

See also: cognitivelibertyuk.wordpress.com

Further References

Nutt, D. J., King, L. A., & Phillips, L. D.. (2010). Drug harms in the UK: A multicriteria decision analysis. The Lancet

Plain numerical DOI: 10.1016/S0140-6736(10)61462-6
DOI URL
directSciHub download

van Amsterdam, J., Nutt, D., Phillips, L., & van den Brink, W.. (2015). European rating of drug harms. Journal of Psychopharmacology, 29(6), 655–660.

Plain numerical DOI: 10.1177/0269881115581980
DOI URL
directSciHub download

Beharry, S., & Gibbons, S.. (2016). An overview of emerging and new psychoactive substances in the United Kingdom. Forensic Science International

Plain numerical DOI: 10.1016/j.forsciint.2016.08.013
DOI URL
directSciHub download

Liechti, M.. (2015). Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling. Swiss Medical Weekly

Plain numerical DOI: 10.4414/smw.2015.14043
DOI URL
directSciHub download

Reuter, P., & Pardo, B.. (2017). Can new psychoactive substances be regulated effectively? An assessment of the British Psychoactive Substances Bill. Addiction, 112(1), 25–31.

Plain numerical DOI: 10.1111/add.13439
DOI URL
directSciHub download

Leave a Reply

Your email address will not be published. Required fields are marked *

24 − 18 =